Login
Toggle navigation
Videos
Categories
Trending
#CEOTalks featuring Romina Parquet, CEO of CIMC Wetrans in Argentina, discuss industry insights and developments with MetroGAS.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tomas Cordoba - CEO - MetroGAS
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Dahrouge Consulting President: Jody Dahrouge | Jody Dahrouge, President of Dahrouge Geological Consulting Ltd.
00:10:00
It looks to invest in global early stage startups in the financial technology space|Andreas Iten,CEO, Co-Founder, and Managing Partner,SIX FinTech Ventures
00:10:00
CEO Viktor Garmiani on Gaining Market Share in a Challenging Environment | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Jeff Ackert, BSc.President, CEO & Director of Cascade Copper Corp
00:10:00
Mchao Resources: Advancing Rare Earth Projects in Malawi with Strong Financial Backing
00:10:00
Advance Auto Parts CEO Tom Greco on Quarterly Earnings, Inflation Impact, and Brand Investment | Tom Greco, CEO, Advance Auto Parts.
00:10:00
Positioning for Success: Easterly Government Properties' Strengths in an Inflationary Market | Bill Trimble, CEO ,Easterly Government Properties Inc.
00:10:00
Investment Strategy in Uranium: A Supply-Demand Mismatch
00:10:00
Invest with Confidence: Dimensional's Strategy for a Calmer Financial Future
00:10:00
China's Dominance in Rare Earth Processing: A National Security Risk
00:10:00
Charles Lehman on Urban Policy and the Jordan Neely Case|Charles Fain Lehman,Professor,Manhattan Institute
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss quarterly results, the lending environment, and more.|Tim Chen is the founder and CEO of NerdWallet.